Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 2, 2013, Pages 347-353

  Patel, Dhavalkumar ^a,b   Hamamdzic, Damir ^a   Llano, Raul ^a   Patel, Daivesh ^a   Cheng, Lan ^a   Fenning, Robert S ^a   Bannan, Khalid ^a   Wilensky, Robert L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

acute coronary syndromes; fibroatheromas; macrophages; myocardial infarction; vulnerable plaque

Indexed keywords

PROTEINASE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; FIBROATHEROMA; FIBROMA; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTRAVASCULAR ULTRASOUND; MALE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SWINE; VASCULAR NECROSIS;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; FIBROSIS; HYPERCHOLESTEROLEMIA; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; NECROSIS; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS; SPECTROSCOPY, NEAR-INFRARED; SWINE; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84872923119     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300710     Document Type: Article

References (23)

1. Boden WE, O'Rourke RA, Teo KK, et al COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516.
2. Madden SP, Sum ST, Muller JE. Assessment of coronary stenosis with near infrared spectroscopy: Coronary stenosis imaging, structure and physiology. In: Escaned J, Serruys PW, eds. Coronary Stenosis Imaging, Structure and Physiology. Toulouse, France: PCR Publishing; 2010:245-261.
3. Gardner CM, Tan H, Hull EL, Lisauskas JB, Sum ST, Meese TM, Jiang C, Madden SP, Caplan JD, Burke AP, Virmani R, Goldstein J, Muller JE. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. J Am Coll Cardiol Cardiovasc Imaging. 2008;1:638-648.
4. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classifca-tion scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
5. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfeld K, Siegel RJ, Tuzcu EM, Yock PG. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478-1492.
6. Mohler ER III, Sarov-Blat L, Shi Y, Hamamdzic D, Zalewski A, Macphee C, Llano R, Pelchovitz D, Mainigi SK, Osman H, Hallman T, Steplewski K, Gertz Z, Lu MM, Wilensky RL. Site-specifc atherogenic gene expression correlates with subsequent variable lesion development in coronary and peripheral vasculature. Arterioscler Thromb Vasc Biol. 2008;28:850-855.
7. Chatzizisis YS, Jonas M, Coskun AU, Beigel R, Stone BV, Maynard C, Gerrity RG, Daley W, Rogers C, Edelman ER, Feldman CL, Stone PH. Prediction of the localization of high-risk coronary atherosclerotic plaques on the basis of low endothelial shear stress: an intravas-cular ultrasound and histopathology natural history study. Circulation. 2008;117:993-1002.
8. Wilensky RL, Shi Y, Mohler ER III, et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med. 2008;14:1059-1066.
9. Rodriguez-Granillo GA, García-García HM, Mc Fadden EP, Valgimigli M, Aoki J, de Feyter P, Serruys PW. In vivo intravascular ultrasound-derived thin-cap fbroatheroma detection using ultrasound radiofre-quency data analysis. J Am Coll Cardiol. 2005;46:2038-2042.
10. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341-355.
11. Deguchi JO, Aikawa M, Tung CH, Aikawa E, Kim DE, Ntziachristos V, Weissleder R, Libby P. Infammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation. 2006;114:55-62.
12. Ohayon J, Finet G, Gharib AM, Herzka DA, Tracqui P, Heroux J, Rioufol G, Kotys MS, Elagha A, Pettigrew RI. Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol. 2008;295:H717-H727.
13. Kubo T, Maehara A, Mintz GS, et al. The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol. 2010;55:1590-1597.
14. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-235.
15. Tanaka A, Imanishi T, Kitabata H, et al. Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: an optical coherence tomography study. Circulation. 2008;118:2368-2373.
16. Toutouzas K, Tsiamis E, Karanasos A, Drakopoulou M, Synetos A, Tsioufs C, Tousoulis D, Davlouros P, Alexopoulos D, Bouki K, Apostolou T, Stefanadis C. Morphological characteristics of culprit ath-eromatic plaque are associated with coronary fow after thrombolytic therapy: new implications of optical coherence tomography from a mul-ticenter study. J Am Coll Cardiol Cardiovasc Interv. 2010;3:507-514.
17. Shi Y, Zhang P, Zhang L, Osman H, Mohler ER 3rd, Macphee C, Zalewski A, Postle A, Wilensky RL. Role of lipoprotein-associated phospholipase A2 in leukocyte activation and infammatory responses. Atherosclerosis. 2007;191:54-62.
18. Hamamdzic D, Fenning RS, Patel D, Mohler ER 3rd, Orlova KA, Wright AC, Llano R, Keane MG, Shannon RP, Birnbaum MJ, Wilensky RL. Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease. Am J Physiol Heart Circ Physiol. 2010;299:H699-H706.
19. Chatzizisis YS, Baker AB, Sukhova GK, Koskinas KC, Papafaklis MI, Beigel R, Jonas M, Coskun AU, Stone BV, Maynard C, Shi GP, Libby P, Feldman CL, Edelman ER, Stone PH. Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothe-lial shear stress colocalize with coronary atheromata with thin fbrous caps in pigs. Circulation. 2011;123:621-630.
20. Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S. Cathepsin cyste-ine proteases in cardiovascular disease. FASEB J. 2007;21:3029-3041.
21. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P, Shi GP. Defciency of cathepsin S reduces atherosclerosis in LDL receptor-defcient mice. J Clin Invest. 2003;111:897-906.
22. Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, Brissette WH, Long CJ, Jackson CL. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2006;26:851-856.
23. de Nooijer R, Bot I, von der Thüsen JH, et al. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:188-194.